NCT00803192View on ClinicalTrials.gov

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2004

Conditions
Bioavailability
Interventions
DRUG

Famotidine Tablets, 40 mg

All Listed Sponsors
lead

Perrigo Company

INDUSTRY

NCT00803192 - Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter